vimarsana.com
Home
Live Updates
Johnson & Johnson Reports Q2 2023 Results : vimarsana.com
Johnson & Johnson Reports Q2 2023 Results
2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and adjusted operational growth of 6.2%*. Operational growth excluding COVID-19 Vaccine of...
Related Keywords
United States
,
Joaquin Duato
,
Biosense Webster
,
Kenvue Inc
,
Abiomed
,
Women Health
,
Company Consumer Health
,
Librexia Program
,
Consumer Health Company
,
Interventional Solutions
,
Exchange Commission
,
Johnson
,
Receptor Antagonist Peptide In Development
,
Consumer Health
,
Skin Health Beauty
,
Johnson Announces Launch Of Kenvue Inc
,
Roadshow
,
Chief Executive
,
Pulmonary Hypertension
,
Infectious Diseases
,
General Surgery
,
Advanced Surgery
,
Current Reports
,
Quarterly Reports
,
Annual Reports
,
Marks First Approval Worldwide
,
Abiraterone Acetate Dual Action Tablet
,
Metastatic Castration Resistant Prostate Cancer
,
Track Designation
,
All Three Indications Under Evaluation
,
Ischemic Stroke
,
Acute Coronary Syndrome
,
Atrial Fibrillation
,
Submits New Drug Application
,
Investigational Single Tablet Combination Therapy
,
Pulmonary Arterial Hypertension
,
Earlier Treatment
,
Refractory Multiple Myeloma
,
Reports First Results
,
Bacillus Calmette Gu
,
Unresponsive Non Muscle Invasive Bladder Cancer
,
Severely Active Ulcerative Colitis
,
Data Published
,
Latest Advancement
,
Highlight Scientific Advances
,
Transform Cancer Care
,
Showcasing Robust
,
Differentiated Portfolio
,
Hematologic Malignancies
,
Solid Tumors
,
Demonstrate Potential Benefit
,
Pregnant Individuals
,
High Risk
,
Early Onset Severe Hemolytic Disease
,
Announces Positive Topline Results
,
Only Oral
,
Antagonist Peptide
,
Moderate To Severe Plaque
,
Statistically Significant
,
Clinically Meaningful Improvement
,
Progression Free Survival
,
Newly Diagnosed
,
Mutation Positive Non Small Cell Lung
,
Johnson Announces Launch
,
Enters Worldwide Collaboration
,
License Agreement
,
Cellular Biomedicine Group
,
Develop Next Generation
,
Euro Average Rate
,
Private Securities Litigation Reform Act
,
New Consumer Health Company
,
Annual Report
,
Note Regarding Forward Looking
,
Consolidated Statement
,
Millions Except Per Share Figures
,
Millions Except Per Share Data
,
Asset Amortization
,
Net Earnings
,
Medical Device Regulation
,
European Medical Devices Directive
,
Sales Reconciliation
,
Before Tax
,
Income Before Tax
,
Business Wire
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.